Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| MiMedx Group, Inc. | MDXG | $3.74 | $545.79M | 93.5 | — |
| Myriad Genetics, Inc. | MYGN | $5.57 | $532.77M | — | |
| Faeth Therapeutics, Inc. | FTH | $20.57 | $531.54M | — | |
| Entera Bio Ltd. | ENTX | $3.05 | $530.19M | — | |
| Tactile Systems Technology, Inc. | TCMD | $23.28 | $527.35M | 21.6 | — |
| Valneva SE | VALN | $5.56 | $527.22M | — | |
| CytomX Therapeutics, Inc. | CTMX | $2.40 | $522.96M | — | |
| Neurogene Inc. | NGNE | $26.08 | $521.90M | — | |
| Fennec Pharmaceuticals Inc. | FRX.TO | CA$14.76 Oct 20, 2026 | CA$517.59M | — | |
| Aquestive Therapeutics, Inc. | AQST | $4.08 | $512.09M | — | |
| Eupraxia Pharmaceuticals Inc. | EPRX | $7.73 | $510.75M | — | |
| Delcath Systems, Inc. | DCTH | $14.70 | $510.07M | 1,470.0 | — |
| AngioDynamics, Inc. | ANGO | $11.89 | $500.03M | — | |
| Bright Minds Biosciences Inc. | DRUG | $50.44 | $497.54M | — | |
| Evolus, Inc. | EOLS | $7.40 | $488.77M | — | |
| 908 Devices Inc. | MASS | $11.80 | $487.74M | — | |
| Arvinas, Inc. | ARVN | $7.56 | $487.46M | 29.1 | — |
| Vitalhub Corp. | VHI.TO | CA$7.69 | CA$487.08M | 64.1 | — |
| Monopar Therapeutics Inc. | MNPR | $72.35 | $485.63M | — | |
| Oculis Holding AG | OCS | $7.87 | $484.70M | — | |
| SS Innovations International, Inc. | SSII | $2.41 | $483.18M | — | |
| Ovid Therapeutics Inc. | OVID | $2.47 | $482.39M | — | |
| BrainsWay Ltd. | BWAY | $11.98 | $479.82M | 51.8 | — |
| Sight Sciences, Inc. | SGHT | $8.70 | $479.27M | — | |
| BlossomHill Therapeutics, Inc. | BLSM | $15.60 | $476.14M | — | |
| REGENXBIO Inc. | RGNX | $7.17 | $473.31M | — | |
| AVITA Medical, Inc. | RCEL | $15.29 | $472.87M | — | |
| DiaMedica Therapeutics Inc. | DMAC | $8.69 | $468.61M | — | |
| Crescent Biopharma, Inc. | CBIO | $13.17 | $467.31M | — | |
| Allogene Therapeutics, Inc. | ALLO | $1.33 | $459.50M | — | |
| Cerus Corporation | CERS | $2.39 | $455.45M | — | |
| MapLight Therapeutics, Inc. | MPLT | $8.16 | $453.50M | — | |
| NRC Health | NRC | $20.31 | $449.25M | 84.6 | 3.09% |
| Kamada Ltd. | KMDA | $7.78 | $448.99M | 20.5 | 2.17% |
| AgomAb Therapeutics NV | AGMB | $9.11 | $448.65M | — | |
| NeuroPace, Inc. | NPCE | $13.05 | $447.93M | — | |
| Altimmune, Inc. | ALT | $2.23 | $433.77M | — | |
| Eikon Therapeutics, Inc. | EIKN | $8.00 | $433.32M | — | |
| Tilray Brands, Inc. | TLRY | $2.92 | $431.54M | — | |
| Autolus Therapeutics plc | AUTL | $1.62 | $431.18M | — | |
| Tectonic Therapeutic, Inc. | TECX | $21.84 | $426.96M | — | |
| Canopy Growth Corporation | WEED.TO | CA$0.94 | CA$422.34M | — | |
| Senseonics Holdings, Inc. | SENS | $7.97 | $421.41M | — | |
| Indaptus Therapeutics, Inc. | INDP | $3.16 | $421.05M | — | |
| Strata Critical Medical, Inc. | SRTA | $4.73 | $418.45M | — | |
| TRex Bio, Inc. | TRXB | $15.24 | $418.27M | — | |
| Assembly Biosciences, Inc. | ASMB | $20.46 | $416.58M | — | — |
| ARS Pharmaceuticals, Inc. | SPRY | $4.18 | $415.69M | — | |
| Prothena Corporation plc | PRTA | $8.03 | $412.24M | — | |
| YD Bio Ltd | YDES | $5.77 | $408.70M | — |
MiMedx Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $545.79M
- P/E
- 93.5
Myriad Genetics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $532.77M
- P/E
- unprofitable
Faeth Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $531.54M
- P/E
- unprofitable
Entera Bio Ltd.
Healthcare / Biotechnology
- Market Cap
- $530.19M
- P/E
- unprofitable
Tactile Systems Technology, Inc.
Healthcare / Medical Devices
- Market Cap
- $527.35M
- P/E
- 21.6
Valneva SE
Healthcare / Biotechnology
- Market Cap
- $527.22M
- P/E
- unprofitable
CytomX Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $522.96M
- P/E
- unprofitable
Neurogene Inc.
Healthcare / Biotechnology
- Market Cap
- $521.90M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- CA$517.59M
- P/E
- unprofitable
Aquestive Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $512.09M
- P/E
- unprofitable
Eupraxia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $510.75M
- P/E
- unprofitable
Delcath Systems, Inc.
Healthcare / Medical Devices
- Market Cap
- $510.07M
- P/E
- 1,470.0
AngioDynamics, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $500.03M
- P/E
- unprofitable
Bright Minds Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $497.54M
- P/E
- unprofitable
Evolus, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $488.77M
- P/E
- unprofitable
908 Devices Inc.
Healthcare / Medical Devices
- Market Cap
- $487.74M
- P/E
- unprofitable
Arvinas, Inc.
Healthcare / Biotechnology
- Market Cap
- $487.46M
- P/E
- 29.1
Vitalhub Corp.
Healthcare / Health Information Services
- Market Cap
- CA$487.08M
- P/E
- 64.1
Monopar Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $485.63M
- P/E
- unprofitable
Oculis Holding AG
Healthcare / Biotechnology
- Market Cap
- $484.70M
- P/E
- unprofitable
SS Innovations International, Inc.
Healthcare / Medical Devices
- Market Cap
- $483.18M
- P/E
- unprofitable
Ovid Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $482.39M
- P/E
- unprofitable
BrainsWay Ltd.
Healthcare / Medical Devices
- Market Cap
- $479.82M
- P/E
- 51.8
Sight Sciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $479.27M
- P/E
- unprofitable
BlossomHill Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $476.14M
- P/E
- unprofitable
REGENXBIO Inc.
Healthcare / Biotechnology
- Market Cap
- $473.31M
- P/E
- unprofitable
AVITA Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $472.87M
- P/E
- unprofitable
DiaMedica Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $468.61M
- P/E
- unprofitable
Crescent Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $467.31M
- P/E
- unprofitable
Allogene Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $459.50M
- P/E
- unprofitable
Cerus Corporation
Healthcare / Medical Devices
- Market Cap
- $455.45M
- P/E
- unprofitable
MapLight Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $453.50M
- P/E
- unprofitable
NRC Health
Healthcare / Health Information Services
- Market Cap
- $449.25M
- P/E
- 84.6
- Dividend Yield
- 3.09%
Kamada Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $448.99M
- P/E
- 20.5
- Dividend Yield
- 2.17%
AgomAb Therapeutics NV
Healthcare / Biotechnology
- Market Cap
- $448.65M
- P/E
- unprofitable
NeuroPace, Inc.
Healthcare / Medical Devices
- Market Cap
- $447.93M
- P/E
- unprofitable
Altimmune, Inc.
Healthcare / Biotechnology
- Market Cap
- $433.77M
- P/E
- unprofitable
Eikon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $433.32M
- P/E
- unprofitable
Tilray Brands, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $431.54M
- P/E
- unprofitable
Autolus Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $431.18M
- P/E
- unprofitable
Tectonic Therapeutic, Inc.
Healthcare / Biotechnology
- Market Cap
- $426.96M
- P/E
- unprofitable
Canopy Growth Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$422.34M
- P/E
- unprofitable
Senseonics Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $421.41M
- P/E
- unprofitable
Indaptus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $421.05M
- P/E
- unprofitable
Strata Critical Medical, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $418.45M
- P/E
- unprofitable
TRex Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $418.27M
- P/E
- unprofitable
Assembly Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $416.58M
ARS Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $415.69M
- P/E
- unprofitable
Prothena Corporation plc
Healthcare / Biotechnology
- Market Cap
- $412.24M
- P/E
- unprofitable
YD Bio Ltd
Healthcare / Biotechnology
- Market Cap
- $408.70M
- P/E
- unprofitable
Showing 451–500 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.